Search results
Results from the WOW.Com Content Network
[2] [30] [38] It is the first nasal spray for the treatment of anaphylaxis approved by the US Food and Drug Administration (FDA). [30] The approval of epinephrine nasal spray is based on four studies in 175 healthy adults, without anaphylaxis, that measured the epinephrine concentrations in the blood following administration of epinephrine ...
U.S. health officials on Friday approved a nasal spray to treat severe allergic reactions, the first needle-free alternative to shots like EpiPen. The Food and Drug Administration said it approved ...
The US Food and Drug Administration has approved the first nasal medicine to treat severe allergies.On 9 August, US health officials approved the first nasal spray to treat allergic reactions from ...
The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and similar ...
She said, “we are over the moon” about the FDA's approval of the spray, which Zacky will start carrying when it becomes available. First marketed in 1901, epinephrine predates the FDA itself. Products like the EpiPen auto-injector, approved in 1987, were authorized based on chemistry and manufacturing data and were not required to prove ...
The Food and Drug Administration said it approved the spray from drugmaker ARS Pharmaceuticals Inc. as an emergency treatment for adults and older children experiencing life-threatening allergic reactions known as anaphylaxis. The spray is intended for people who weigh at least 66 pounds.
(Reuters) -The U.S. Food and Drug Administration has approved ARS Pharmaceuticals' nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions. The spray ...
In 2003, Hollister-Stier received approval from the FDA to market an epinephrine autoinjector called Twinject that could deliver two shots of epinephrine, which it had spent ten years developing. [22] [23] [24] In 2005, it sold the product to Verus Pharmaceuticals, [22] which launched the product the same year. [25]